AkermanM, AlvesVA, BubendorfL. How technology is reshaping the practice of nongynecologic cytology. Acta Cytol.2007; 51: 123–152.
2.
AparicioS, HuntsmanD. Does massively parallel DNA rese-quencing signify the end of histopathology as we know it?J Pathol.2009; 220: 307–315.
3.
EddyaniM, FragaAG, SchmittF. Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol.2009; 47: 1700–1704.
4.
EloyC, AmendoeiraI, SchmittFC. Fine-needle aspiration as an alternative method for frozen tissue banking of breast cancer. Diagn Cytopathol.2009; 37: 76–77.
5.
GomesAL, BardalesRH, MilaneziF, ReisRM, SchmittF. Molecular analysis of c-Kit and PDGFRA in GISTs diagnosed by EUS. Am J Clin Pathol.2007; 127: 1–8.
6.
Longatto-FilhoA, SchmittFC. Gynaecological cytology: too old to be a pop star but too young to die. Diagn Cytopathol.2007; 35: 672–673.
7.
Longatto-FilhoA, GonçalvesA, MartinhoO, SchmittFC, ReisR. Liquid based cytology in DNA based molecular research. Anal Quant Cytol Histol.2009; 31: 395–400.
8.
MilaneziF, CarvalhoS, SchmittFC. EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy. Expert Rev Mol Diagn.2008; 8: 417–434.
9.
Reis-FilhoJS, MilaneziF, CarvalhoS. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chro-mogenic in situ hybridization analysis. Breast Cancer Res.2005; 7: R1028–R1035.
10.
SchmittFC. Cells carry the clue for targeted treatment: a new horizon for cytopathology. Cytopathology.2007; 18: 275–277.
